- Report
- February 2026
- 147 Pages
Global
From €3534EUR$3,950USD£3,022GBP
- Report
- August 2025
- 186 Pages
Global
From €4026EUR$4,500USD£3,443GBP
- Report
- March 2026
- 153 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- December 2025
- 150 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- January 2026
- 160 Pages
Global
From €2827EUR$3,160USD£2,418GBP
€3534EUR$3,950USD£3,022GBP
- Report
- November 2025
- 160 Pages
Global
From €2827EUR$3,160USD£2,418GBP
€3534EUR$3,950USD£3,022GBP
- Report
- November 2025
- 160 Pages
Global
From €2827EUR$3,160USD£2,418GBP
€3534EUR$3,950USD£3,022GBP
- Report
- August 2025
- 358 Pages
Global
From €3221EUR$3,600USD£2,755GBP
- Report
- February 2026
- 111 Pages
Global
From €3500EUR$4,190USD£3,098GBP
- Report
- November 2025
- 112 Pages
Global
From €3500EUR$4,190USD£3,098GBP
From €2282EUR$2,550USD£1,951GBP
- Report
- February 2026
- 159 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- November 2025
- 83 Pages
Global
From €3500EUR$4,190USD£3,098GBP
- Report
- April 2026
- 174 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- March 2026
- 200 Pages
Global
From €4026EUR$4,500USD£3,443GBP
- Report
- October 2025
- 80 Pages
Global
From €4026EUR$4,500USD£3,443GBP
- Report
- October 2025
- 153 Pages
Global
From €4161EUR$4,650USD£3,558GBP
- Report
- April 2026
- 150 Pages
United States
From €3534EUR$3,950USD£3,022GBP
- Report
- July 2026
- 161 Pages
North America
From €4250EUR$4,750USD£3,635GBP
- Report
- April 2026
- 195 Pages
United States
From €2237EUR$2,500USD£1,913GBP

The Real World Evidence (RWE) market within the context of E-Healthcare is a rapidly growing sector. It is a form of evidence-based medicine that uses data from real-world sources such as patient records, claims data, and observational studies to inform healthcare decisions. RWE can be used to assess the safety and effectiveness of treatments, identify new indications for existing treatments, and inform healthcare policy. It can also be used to assess the cost-effectiveness of treatments and to identify potential areas of improvement in healthcare delivery.
RWE is increasingly being used by healthcare providers, payers, and pharmaceutical companies to inform their decisions. It is also being used by researchers to gain insights into the effectiveness of treatments and to identify potential areas of improvement in healthcare delivery.
Some companies in the RWE market include IBM Watson Health, Optum, Flatiron Health, and Evidation Health. Show Less Read more